1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Agwa, A.J. Schroeder, C.I. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE Biochim. Biophys. Acta BBACAQ 0113 0006-3002 1859 835 844 10.1016/j.bbamem.2017.01.020 28115115 Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7. 2017 10.2210/pdb5tlr/pdb pdb_00005tlr 4036.820 Mu-theraphotoxin-Hs2a UNP residues 54-87 E56G, Y58W, F85W 1 syn polymer Mu-TRTX-Hs2a,Huwentoxin-4,Huwentoxin-IV,HwTx-IV,Huwentoxin-IVa,HWTX-IVa,Huwentoxin-IVb,HWTX-IVb,Huwentoxin-IVc,HWTX-IVc no yes GCLGIWKACNPSNDQCCKSSKLVCSRKTRWCKWQI(NH2) GCLGIWKACNPSNDQCCKSSKLVCSRKTRWCKWQIX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n entity pdbx_audit_support pdbx_audit_support pdbx_nmr_software pdbx_nmr_spectrometer database_2 pdbx_database_status repository Initial release Database references Author supporting evidence Structure summary Author supporting evidence Data collection Database references Other 1 0 2017-02-22 1 1 2017-03-01 1 2 2017-09-27 1 3 2020-01-08 1 4 2023-06-14 _entity.pdbx_number_of_molecules _pdbx_audit_support.funding_organization _pdbx_audit_support.funding_organization _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data Australia National Health and Medical Research Council (NHMRC, Australia) APP1080405 gHwTx-IV N RCSB Y RCSB 2016-10-11 REL REL REL REL 29017 Chinese bird spider Haplopelma schmidti sample 1 36 all calculated structures submitted 50 20 isotropic 1 1D 1H isotropic 1 2D 1H-1H TOCSY isotropic 1 2D 1H-1H NOESY isotropic 1 2D 1H-15N HSQC isotropic 1 2D 1H-13C HSQC isotropic 1 2D E.COSY isotropic 1 2D 1H-1H TOCSY isotropic 1 2D 1H-1H NOESY isotropic 1 1D 1H isotropic 2 2D 1H-1H TOCSY isotropic 2 1D 1H 90 % none 10 % none 100 % none Not defined gHwTx-IV_H2O 4.0 pH ambient 298 K Not defined gHwTx-IV_D2O 4.0 pH ambient 298 K Temperature variation experiment with temperatures ranging from 283 - 308 K Not defined gHwTx-IV_Tempvar 4.0 pH ambient 283 K the structures are based on a total of 437 restraints, 385 are NOE-derived distance constraints, 10 distance restraints from hydrogen bonds, 42 dihedral angle restraints torsion angle dynamics 1 fewest violations 90 % H2O, 10 % D2O, 90% H2O/10% D2O gHwTx-IV_H2O 90% H2O/10% D2O solution 100 % D2O, 100% D2O gHwTx-IV_D2O 100% D2O solution Bruker Biospin collection TopSpin CCPN chemical shift assignment CcpNMR Guntert, Mumenthaler and Wuthrich structure calculation CYANA Cornilescu, Delaglio and Bax data analysis TALOS-N Brunger, Adams, Clore, Gros, Nilges and Read refinement CNS Richardson data analysis MolProbity Cryoprobe 600 Bruker AVANCE 500 Bruker AVANCE GLY 1 n 1 GLY 1 A CYS 2 n 2 CYS 2 A LEU 3 n 3 LEU 3 A GLY 4 n 4 GLY 4 A ILE 5 n 5 ILE 5 A TRP 6 n 6 TRP 6 A LYS 7 n 7 LYS 7 A ALA 8 n 8 ALA 8 A CYS 9 n 9 CYS 9 A ASN 10 n 10 ASN 10 A PRO 11 n 11 PRO 11 A SER 12 n 12 SER 12 A ASN 13 n 13 ASN 13 A ASP 14 n 14 ASP 14 A GLN 15 n 15 GLN 15 A CYS 16 n 16 CYS 16 A CYS 17 n 17 CYS 17 A LYS 18 n 18 LYS 18 A SER 19 n 19 SER 19 A SER 20 n 20 SER 20 A LYS 21 n 21 LYS 21 A LEU 22 n 22 LEU 22 A VAL 23 n 23 VAL 23 A CYS 24 n 24 CYS 24 A SER 25 n 25 SER 25 A ARG 26 n 26 ARG 26 A LYS 27 n 27 LYS 27 A THR 28 n 28 THR 28 A ARG 29 n 29 ARG 29 A TRP 30 n 30 TRP 30 A CYS 31 n 31 CYS 31 A LYS 32 n 32 LYS 32 A TRP 33 n 33 TRP 33 A GLN 34 n 34 GLN 34 A ILE 35 n 35 ILE 35 A NH2 36 n 36 NH2 36 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N VAL 23 A N VAL 23 A O LYS 32 A O LYS 32 6 A A OD1 HZ1 ASP LYS 14 18 1.57 1 A ASN 13 -150.38 75.51 1 A GLN 15 -139.18 -75.90 1 A CYS 16 51.32 -150.63 1 A TRP 33 -106.84 -78.87 2 A GLN 15 -140.55 -65.66 2 A CYS 16 54.39 -151.05 3 A GLN 15 -131.95 -59.47 3 A CYS 16 51.52 -148.70 3 A ARG 29 54.94 81.96 4 A ASN 13 -150.98 88.96 4 A GLN 15 -147.32 -71.19 4 A CYS 16 52.12 -138.72 5 A GLN 15 -133.20 -75.49 5 A CYS 16 51.45 -146.50 5 A ARG 29 50.92 79.75 6 A GLN 15 -148.45 -75.02 6 A CYS 16 56.27 -155.90 6 A ARG 29 58.33 77.08 6 A GLN 34 -179.40 -35.89 7 A GLN 15 -128.57 -63.56 7 A CYS 16 48.10 -156.41 7 A THR 28 -150.23 -95.56 7 A ARG 29 169.65 84.58 8 A GLN 15 -140.57 -75.94 8 A CYS 16 51.53 -145.34 8 A ARG 29 61.49 85.64 8 A TRP 30 -173.13 -179.30 9 A GLN 15 -145.77 -75.59 9 A CYS 16 53.24 -148.44 9 A ARG 29 62.15 70.15 10 A GLN 15 -123.42 -52.75 10 A CYS 16 56.51 -148.53 10 A LYS 21 63.96 61.42 11 A ASN 13 -159.20 81.64 11 A GLN 15 -135.64 -42.24 11 A CYS 16 51.85 -148.73 11 A ARG 29 63.22 63.84 11 A GLN 34 -135.91 -42.91 12 A GLN 15 -147.43 -75.79 12 A CYS 16 50.97 -136.17 12 A ARG 29 59.01 85.90 13 A CYS 2 66.60 173.58 13 A GLN 15 -152.68 -70.72 13 A CYS 16 54.56 -142.15 13 A LYS 21 67.42 61.33 13 A ARG 29 57.94 77.12 14 A CYS 2 65.02 173.79 14 A GLN 15 -145.68 -67.69 14 A CYS 16 55.11 -139.69 14 A ARG 29 51.72 79.61 15 A GLN 15 -139.70 -73.57 15 A CYS 16 56.09 -152.92 15 A LYS 21 70.69 49.29 15 A GLN 34 -175.33 -27.48 16 A GLN 15 -156.70 -75.37 16 A CYS 16 50.72 -144.75 16 A GLN 34 -73.75 -159.68 17 A ASN 13 -152.87 73.13 17 A GLN 15 -142.59 -75.79 17 A CYS 16 51.87 -142.54 17 A ARG 26 -96.93 -62.15 18 A CYS 2 70.84 168.32 18 A ASN 13 -153.80 83.71 18 A GLN 15 -113.60 -72.32 18 A CYS 16 53.32 -159.70 18 A ARG 26 -104.41 -61.61 18 A ARG 29 57.67 76.75 19 A GLN 15 -134.33 -75.45 19 A CYS 16 55.45 -150.14 19 A THR 28 -150.38 -92.16 19 A ARG 29 169.73 81.75 20 A GLN 15 -133.94 -75.29 20 A CYS 16 50.94 -146.92 20 A ARG 29 58.13 75.04 refinement CNS N Solution NMR structure of gHwTx-IV 1 N N disulf 2.030 A CYS 2 A SG CYS 2 1_555 A CYS 17 A SG CYS 17 1_555 disulf 2.020 A CYS 9 A SG CYS 9 1_555 A CYS 24 A SG CYS 24 1_555 disulf 2.015 A CYS 16 A SG CYS 16 1_555 A CYS 31 A SG CYS 31 1_555 covale 1.300 both A ILE 35 A C ILE 35 1_555 A NH2 36 A N NH2 36 1_555 TOXIN spider toxin, disulfide-rich, sodium channel inhibitor, TOXIN TXH4_HAPSC UNP 1 54 P83303 CLEIFKACNPSNDQCCKSSKLVCSRKTRWCKYQI 54 87 5TLR 2 35 P83303 A 1 2 35 1 insertion GLY 1 5TLR A P83303 UNP 1 1 GLU engineered mutation GLY 4 5TLR A P83303 UNP 56 4 1 PHE engineered mutation TRP 6 5TLR A P83303 UNP 58 6 1 TYR engineered mutation TRP 33 5TLR A P83303 UNP 85 33 1 amidation NH2 36 5TLR A P83303 UNP 36 2 anti-parallel A VAL 23 A VAL 23 A CYS 24 A CYS 24 A CYS 31 A CYS 31 A LYS 32 A LYS 32